@article{e6d4a94c63784e2d81c8c065f2ab123c,
title = "The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practice",
author = "Bradley, \{Corey K.\} and Peter Shrader and Sanchez, \{Robert J.\} and Peterson, \{Eric D.\} and Navar, \{Ann Marie\}",
note = "Most PCSK9 inhibitor users in community practice were not on a statin, presumably because of statin intolerance. The drug approval process and costs continue to be strong reasons for lower initiation of PCSK9 agents, as well as higher discontinuation rates.",
year = "2019",
month = jul,
day = "2",
doi = "10.1016/J.JACL.2019.06.008",
language = "American English",
volume = "13",
journal = "Journal of Clinical Lipidology",
number = "5",
}